Full-Time

Systems Administrator 2

Nivagen Pharmaceuticals

Nivagen Pharmaceuticals

51-200 employees

Develops, acquires, and markets generic drugs

Compensation Overview

$100k - $120k/yr

+ Yearly bonus eligibility

Sacramento, CA, USA

In Person

Must live or be willing to relocate within approximately 40 miles of the Sacramento metropolitan region.

Bachelor's

Category
IT & Security (1)
Required Skills
TCP/IP
LDAP
Computer Networking

Get referred to Nivagen Pharmaceuticals

See people who can refer or advise you

Requirements
  • A Bachelor's degree from a four-year college or university with two years of related experience and/or training, or six years of related experience and/or training.
  • Certifications from Systems Administrator I plus Microsoft MS-900; AWS Cloud Practitioner and SysOps Administrator or Architect; CompTIA Security+; Microsoft AZ-900 and SC-900; and VMware VCTA-DCV and VCP-DCV certifications.
  • Must live or be willing to relocate to the Sacramento metropolitan region within approximately a 40-mile radius.
  • Ability to read, analyze, and interpret business periodicals, professional journals, technical procedures, and government regulations; write reports, business correspondence, and procedure manuals; and present information to managers, customers, coworkers, and vendors.
  • Ability to calculate figures and amounts using basic algebra and geometry.
  • Ability to solve practical problems with limited standardization and interpret written, verbal, diagrammatic, or schedule-based instructions.
  • Knowledge of system management, including system configuration, troubleshooting, security, resource monitoring, and specialized program development.
  • Knowledge of network management, TCP/IP, DNS management, email infrastructure management, and Active Directory.
Responsibilities
  • Serve as a subject matter expert on one or more technology platforms owned by IT Operations.
  • Produce system upgrade roadmaps for assigned technology platforms and execute the plans.
  • Produce, tune, configure, patch, and upgrade operating systems for servers and workstations.
  • Assess system performance and report findings to management.
  • Monitor system backups, perform data restores, and troubleshoot issues as needed.
  • Assess hardware and software vendors and third-party hardware and software, and report significant findings to the Systems Services Manager.
  • Produce standard operating procedures used by the Systems Services and Technical Support Services teams.
  • Perform system and workstation maintenance and troubleshooting.
  • Develop scripts to install applications and patches and perform routine maintenance on servers and workstations.
  • Develop and execute plans to ensure assigned systems are patched and compliant with approved software versions.
  • Provide end-user support in accordance with established IT service-level agreements.
  • Serve as an IT Process Lead within the System Services team when assigned.
  • Serve on project teams as a subject matter expert for assigned areas within the System Services team.
  • Provide technical assistance with enterprise disaster planning and recovery.
  • Develop and maintain system problem-analysis and resolution techniques and resolve system problems efficiently.
  • Define development tools and procedures for daily operational support and support application activities requiring specialized system programming.
  • Evaluate software products, including installation, testing, and technical support, and provide technical consultation and specialized programming for applications and operations.
  • Maintain contact with computer vendors and other technical support personnel and coordinate with enterprise help desk, application, operations, and non-IT personnel for troubleshooting and specification development.
  • Provide planning and technical support for enterprise installations at central and remote facilities and provide network support for operations and the technical-support computing environment.
  • Serve on employee committees and coordinate activities with other departments and work groups.
  • Provide backup for related positions as assigned.
Nivagen Pharmaceuticals

Nivagen Pharmaceuticals

View

Nivagen Pharmaceuticals develops, acquires, and sells generic prescription drugs and OTC products for the North American market. It leverages global partnerships with FDA-approved manufacturing facilities to deliver high-quality, affordable products and collaborates with the world’s best CROs and CRAMs to develop and manufacture niche generics. The company supports small FDA-qualified manufacturers entering the U.S. market and differentiates itself through its ability to launch new generic products and its strong sales and marketing team, rather than relying on a single manufacturing or development approach. Revenue comes from product development, co-development, acquisitions, in-licensing, and providing sales and marketing services. Nivagen aims to grow its portfolio by forging CRO/CRAM partnerships, acquiring existing products, and expanding its product lineup to capture a larger share of the evolving generic and OTC market in North America.

Company Size

51-200

Company Stage

Growth Equity (Venture Capital)

Total Funding

$26M

Headquarters

Sacramento, California

Founded

2009

Get referred to Nivagen Pharmaceuticals

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • PAI Pharma's January 6, 2026 acquisition brings Olympus-backed capital and distribution.
  • Owning the Sacramento site after February 2026 strengthens expansion and regulatory control.
  • Shortage-sensitive injectable demand supports faster commercialization for Nivagen's RTU pipeline.

What critics are saying

  • Nivagen's zinc oxide Class II recall, started October 31, 2025, remains ongoing.
  • California recalled atorvastatin tablets in September 2024 for a carbamazepine mix-up.
  • Repeated cGMP failures or sterile contamination would trigger FDA shutdowns and destroy hospital trust.

What makes Nivagen Pharmaceuticals unique

  • Sacramento's 100,000-square-foot sterile facility makes Nivagen unusually domestic for injectables.
  • Nivagen built over 20 ready-to-use sterile injectables before PAI Pharma's January 2026 acquisition.
  • Its 503B compounding and CDMO services target shortage-driven hospital demand directly.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Time Off

401 (k) savings plan

Growth & Insights and Company News

Headcount

6 month growth

-4%

1 year growth

-4%

2 year growth

-7%
PE Hub
Jan 6th, 2026
Olympus-backed PAI Pharma picks up Nivagen Pharmaceuticals

Olympus-backed PAI Pharma picks up Nivagen Pharmaceuticals. Headquartered in Greenville, South Carolina, PAI is a developer, manufacturer and marketer of oral liquid medicines. * Nivagen operates an aseptic manufacturing facility in Sacramento, California, designed to support the production of IV bags, vials, prefilled syringes, and cartridges * Nivagen was founded in 2009 PAI Pharma, which is backed by Olympus Partners, has acquired Nivagen Pharmaceuticals, Inc, a Sacramento, California-based pharmaceutical company. No financial terms were disclosed. Gain instant access to our expert editorial analysis and in-depth insight. Already have an account? Sign in.

Benzinga
Jan 6th, 2026
PAI Pharma acquires Nivagen to expand US sterile injectable manufacturing amid persistent drug shortages

PAI Pharma, a portfolio company of Olympus Partners, has acquired Nivagen Pharmaceuticals, a California-based pharmaceutical company specialising in ready-to-use sterile injectables. The deal expands PAI's domestic manufacturing capabilities and addresses persistent drug shortages in the US healthcare system. Nivagen operates a state-of-the-art aseptic manufacturing facility in Sacramento, producing IV bags, vials, prefilled syringes and cartridges. The company brings over 20 injectable products to complement PAI's existing sterile portfolio of approximately 10 products in development and four on the market. The acquisition aligns with growing efforts to reshore pharmaceutical production and reduce reliance on foreign supply chains. PAI Pharma was advised by Bourne Partners, Kirkland & Ellis and KPMG, whilst Olympus Partners provided backing for the transaction.

Private Equity Info
Aug 22nd, 2022
Corbel Capital Partners invests into Nivagen Pharmaceuticals, Inc.

Corbel Capital Partners invested in Nivagen Pharmaceuticals (Sacramento, CA, US), a specialty pharmaceuticals business that develops and sells generic and branded prescription drugs.